Injectable Drug Delivery News

  1. Piramal Pharma Solutions Holds Grand Opening Ceremony For New API Plant At Aurora, Canada Manufacturing Site 7/12/2022

    Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), held a Grand Opening to celebrate the official inauguration of a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario.

  2. Fill/Finish CMO Announces New Sterility Testing Isolator Technology For GMP Batches 6/28/2022

    Berkshire Sterile Manufacturing (BSM), a fill finish CMO located in Lee, MA, is proud to announce their sterility testing isolator is ready to perform onsite sterility testing for its GMP batches. The new service is expected to shorten the release for most, if not all the company’s clients.

  3. Kindeva Drug Delivery Announces Collaboration With Synopsys 6/15/2022

    Kindeva Drug Delivery (Kindeva) has announced a collaboration with Synopsys, Inc. involving the implementation of Synopsys Simpleware™ automated software solutions to assist in creating a state-of-the-art system for accurately measuring Kindeva’s microstructured transdermal system (MTS) arrays.

  4. West Introduces Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System At BIO International Convention 6/13/2022

    Daikyo Crystal Zenith® (CZ®) is a technologically advanced cyclic olefin polymer containment and delivery system that offers an alternative to glass, mitigating the risk of breakage and reducing the chance of particulates, contamination, and extractables.

  5. Societal CDMO Announces Key New Customer Project Within Automated Fill/Finish And Lyophilization Unit At San Diego Facility 6/8/2022

    Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced a key new customer project utilizing its automated fill/finish line and lyophilization unit at the company’s San Diego facility

  6. WuXi Biologics Launches First Commercial Drug Product Facility For Pre-Filled Syringes 6/5/2022

    WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility DP5 located in Wuxi, China.

  7. Strategic Investment Increases xRNA-Based LNP Formulation Services At Caponago Injectable Facility 6/1/2022

    CordenPharma, a full-service Contract Development Manufacturing Organization (CDMO) of Active Pharmaceutical Ingredients (APIs), Excipients, Drug Products & Packaging services, has increased its xRNA capabilities at its sterile injectable facility in Caponago, Italy

  8. Piramal Pharma Solutions Upgrades Oral Solid Dose Capabilities With New Production Block At Pithampur Site 5/24/2022

    Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), today announced a new production block has come online at the company's drug product site in Pithampur, in the state of Madhya Pradesh, India

  9. BD And Mitsubishi Gas Chemical Have Signed A Letter Of Intent (LOI) To Discuss A Partnership Agreement To Explore New Ways To Advance Biologic Drug Delivery 5/19/2022

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. (MGC), a R&D-oriented chemical manufacturer based in Tokyo, Japan, today announced that they have entered into an agreement to investigate further development of OXYCAPT™ - an innovation from MGC that integrates the best of plastic and glass for plastic syringes.

  10. Piramal Pharma Solutions New API Plant In Canada Goes Online; Initial Production Runs Successfully Completed 5/19/2022

    Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), today announced that a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario, has come online and successfully completed its initial production runs